Home › Funds › Parkman Healthcare Partners LLC › ABSI
Parkman Healthcare Partners LLC position in ABSI
ABSCI CORPORATION · Health Care
Parkman Healthcare Partners LLC reported holding 894,374 shares of ABSI (ABSCI CORPORATION) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 1.06% of its reported portfolio and ranking #38 among its reported holdings. Parkman Healthcare Partners LLC has disclosed ABSI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's ABSI position evolved
Parkman Healthcare Partners LLC first disclosed a stake in ABSI in Q4 2025 at 1,458,652 shares (US$5.1M). The position peaked in Q2 2026 at 894,374 shares, worth US$10.4M. Across 3 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 894,374 shares valued at US$10.4M — a reduction of -970,432 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2026 (shares rose 286% over the following quarter), a 52% trim in Q2 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.46M | $5.09M | New |
| Q1 2026 | 1.86M | $5.59M | Add |
| Q2 2026 | 894.37K | $10.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABSI and 13F data
ABSI (ABSCI CORPORATION) is a Health Care company. 68 other funds we track also report a position in ABSI — the largest reported positions include ARK Invest (US$149.8M), Redmile Group, LLC (US$78.1M), ADVANCED MICRO DEVICES INC (US$66.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABSI
- ARK Invest 12.93M sh · $149.80M · Q2 2026
- Redmile Group, LLC 6.74M sh · $78.11M · Q2 2026
- ADVANCED MICRO DEVICES INC 5.71M sh · $66.23M · Q2 2026
- Siren, L.L.C. 2.47M sh · $28.68M · Q2 2026
- BVF INC/IL 2.36M sh · $27.37M · Q2 2026
- Gem Investment Advisors, LLC 2.17M sh · $25.16M · Q2 2026
- BAKER BROS. ADVISORS LP 2.13M sh · $24.74M · Q2 2026
- Casdin Capital 973.26K sh · $11.28M · Q2 2026
- Artia Global Partners LP 464.44K sh · $5.38M · Q2 2026
- Ikarian Capital, LLC 353.77K sh · $4.10M · Q2 2026
- Sofinnova Investments, Inc. 337.40K sh · $3.91M · Q2 2026
- Palumbo Wealth Management LLC 183.19K sh · $2.12M · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held ABSI?
Parkman Healthcare Partners LLC has disclosed ABSI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Parkman Healthcare Partners LLC's current position in ABSI?
As of Q2 2026, Parkman Healthcare Partners LLC holds 894.37K shares of ABSI (ABSCI CORPORATION), valued at $10.37M, representing 1.06% of its reported portfolio and ranking #38.
Has Parkman Healthcare Partners LLC been buying or selling ABSI?
In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC reduced its position in ABSI. The position peaked in Q2 2026 at 894.37K shares.
Which other funds hold ABSI?
Other major institutional holders of ABSI include ARK Invest, Redmile Group, LLC, ADVANCED MICRO DEVICES INC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.